drugset
drugset / Trial / NCT00432198

Zolpidem Postmarketing Study in Adolescent Patients With Insomnia

NCT00432198 ↗

Phase 4 Completed 122 enrolled Astellas Pharma Inc
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To investigate the efficacy and safety of zolpidem for pediatric insomniacs in a randomized double blind-controlled trial

Timeline

Start
2007-02
Primary completion
2010-01
Completion
2010-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Zolpidem Small molecule — Oral

Indications

insomnia